IBDEI024 ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2288,0)
 ;;=J9260^^24^176^29^^^^1
 ;;^UTILITY(U,$J,358.3,2288,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2288,1,1,0)
 ;;=1^J9260
 ;;^UTILITY(U,$J,358.3,2288,1,3,0)
 ;;=3^Methotrexate Sodium 50mgs
 ;;^UTILITY(U,$J,358.3,2289,0)
 ;;=J9265^^24^176^33^^^^1
 ;;^UTILITY(U,$J,358.3,2289,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2289,1,1,0)
 ;;=1^J9265
 ;;^UTILITY(U,$J,358.3,2289,1,3,0)
 ;;=3^Paclitaxel 30mgs
 ;;^UTILITY(U,$J,358.3,2290,0)
 ;;=J9293^^24^176^31^^^^1
 ;;^UTILITY(U,$J,358.3,2290,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2290,1,1,0)
 ;;=1^J9293
 ;;^UTILITY(U,$J,358.3,2290,1,3,0)
 ;;=3^Mitoxantrone HCl(Novan)5mgs
 ;;^UTILITY(U,$J,358.3,2291,0)
 ;;=J9310^^24^176^34^^^^1
 ;;^UTILITY(U,$J,358.3,2291,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2291,1,1,0)
 ;;=1^J9310
 ;;^UTILITY(U,$J,358.3,2291,1,3,0)
 ;;=3^Rituxan 100mg
 ;;^UTILITY(U,$J,358.3,2292,0)
 ;;=J9360^^24^176^36^^^^1
 ;;^UTILITY(U,$J,358.3,2292,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2292,1,1,0)
 ;;=1^J9360
 ;;^UTILITY(U,$J,358.3,2292,1,3,0)
 ;;=3^Vinblastine Sulfate (Velban) 1mg
 ;;^UTILITY(U,$J,358.3,2293,0)
 ;;=J9370^^24^176^37^^^^1
 ;;^UTILITY(U,$J,358.3,2293,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2293,1,1,0)
 ;;=1^J9370
 ;;^UTILITY(U,$J,358.3,2293,1,3,0)
 ;;=3^Vincristine Sulfate(VCR) 1mg
 ;;^UTILITY(U,$J,358.3,2294,0)
 ;;=J9390^^24^176^32^^^^1
 ;;^UTILITY(U,$J,358.3,2294,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2294,1,1,0)
 ;;=1^J9390
 ;;^UTILITY(U,$J,358.3,2294,1,3,0)
 ;;=3^Navelbine 10mgs
 ;;^UTILITY(U,$J,358.3,2295,0)
 ;;=J9171^^24^176^14^^^^1
 ;;^UTILITY(U,$J,358.3,2295,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2295,1,1,0)
 ;;=1^J9171
 ;;^UTILITY(U,$J,358.3,2295,1,3,0)
 ;;=3^Docetaxel 1 mg
 ;;^UTILITY(U,$J,358.3,2296,0)
 ;;=J9070^^24^176^11^^^^1
 ;;^UTILITY(U,$J,358.3,2296,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2296,1,1,0)
 ;;=1^J9070
 ;;^UTILITY(U,$J,358.3,2296,1,3,0)
 ;;=3^Cyclophosphamide 100mg Inj
 ;;^UTILITY(U,$J,358.3,2297,0)
 ;;=J9351^^24^176^35^^^^1
 ;;^UTILITY(U,$J,358.3,2297,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2297,1,1,0)
 ;;=1^J9351
 ;;^UTILITY(U,$J,358.3,2297,1,3,0)
 ;;=3^Topotecan 0.1mg
 ;;^UTILITY(U,$J,358.3,2298,0)
 ;;=J9035^^24^176^3^^^^1
 ;;^UTILITY(U,$J,358.3,2298,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2298,1,1,0)
 ;;=1^J9035
 ;;^UTILITY(U,$J,358.3,2298,1,3,0)
 ;;=3^Bevacizumab Inj,10mg
 ;;^UTILITY(U,$J,358.3,2299,0)
 ;;=J9041^^24^176^5^^^^1
 ;;^UTILITY(U,$J,358.3,2299,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2299,1,1,0)
 ;;=1^J9041
 ;;^UTILITY(U,$J,358.3,2299,1,3,0)
 ;;=3^Bortezomib Inj, 0.1mg
 ;;^UTILITY(U,$J,358.3,2300,0)
 ;;=J9045^^24^176^8^^^^1
 ;;^UTILITY(U,$J,358.3,2300,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2300,1,1,0)
 ;;=1^J9045
 ;;^UTILITY(U,$J,358.3,2300,1,3,0)
 ;;=3^Carboplatin Inj, 50mg
 ;;^UTILITY(U,$J,358.3,2301,0)
 ;;=J9055^^24^176^9^^^^1
 ;;^UTILITY(U,$J,358.3,2301,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2301,1,1,0)
 ;;=1^J9055
 ;;^UTILITY(U,$J,358.3,2301,1,3,0)
 ;;=3^Cetuximab Inj, 10mg
 ;;^UTILITY(U,$J,358.3,2302,0)
 ;;=J8530^^24^176^12^^^^1
 ;;^UTILITY(U,$J,358.3,2302,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2302,1,1,0)
 ;;=1^J8530
 ;;^UTILITY(U,$J,358.3,2302,1,3,0)
 ;;=3^Cyclophosphamide Oral, 25mg
 ;;^UTILITY(U,$J,358.3,2303,0)
 ;;=J9206^^24^176^25^^^^1
 ;;^UTILITY(U,$J,358.3,2303,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2303,1,1,0)
 ;;=1^J9206
 ;;^UTILITY(U,$J,358.3,2303,1,3,0)
 ;;=3^Irinotecan Inj, 20mg
 ;;^UTILITY(U,$J,358.3,2304,0)
 ;;=J0135^^24^176^1^^^^1
 ;;^UTILITY(U,$J,358.3,2304,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2304,1,1,0)
 ;;=1^J0135
 ;;^UTILITY(U,$J,358.3,2304,1,3,0)
 ;;=3^Adalimumab Inj 20mg
 ;;^UTILITY(U,$J,358.3,2305,0)
 ;;=J9002^^24^176^16^^^^1
 ;;^UTILITY(U,$J,358.3,2305,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2305,1,1,0)
 ;;=1^J9002
 ;;^UTILITY(U,$J,358.3,2305,1,3,0)
 ;;=3^Doxorubicin,liposome,10mg
 ;;^UTILITY(U,$J,358.3,2306,0)
 ;;=P9010^^24^177^22^^^^1
 ;;^UTILITY(U,$J,358.3,2306,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2306,1,1,0)
 ;;=1^P9010
 ;;^UTILITY(U,$J,358.3,2306,1,3,0)
 ;;=3^Whole Blood,Ea Unit
 ;;^UTILITY(U,$J,358.3,2307,0)
 ;;=P9012^^24^177^4^^^^1
 ;;^UTILITY(U,$J,358.3,2307,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2307,1,1,0)
 ;;=1^P9012
 ;;^UTILITY(U,$J,358.3,2307,1,3,0)
 ;;=3^Cryoprecipitate,Ea Unit
 ;;^UTILITY(U,$J,358.3,2308,0)
 ;;=P9016^^24^177^18^^^^1
 ;;^UTILITY(U,$J,358.3,2308,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2308,1,1,0)
 ;;=1^P9016
 ;;^UTILITY(U,$J,358.3,2308,1,3,0)
 ;;=3^RBC Leukocytes Reduced
 ;;^UTILITY(U,$J,358.3,2309,0)
 ;;=P9017^^24^177^6^^^^1
 ;;^UTILITY(U,$J,358.3,2309,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2309,1,1,0)
 ;;=1^P9017
 ;;^UTILITY(U,$J,358.3,2309,1,3,0)
 ;;=3^Plasma 1 Donor Frz w/in 8hrs
 ;;^UTILITY(U,$J,358.3,2310,0)
 ;;=P9019^^24^177^10^^^^1
 ;;^UTILITY(U,$J,358.3,2310,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2310,1,1,0)
 ;;=1^P9019
 ;;^UTILITY(U,$J,358.3,2310,1,3,0)
 ;;=3^Platelets,Ea Unit
 ;;^UTILITY(U,$J,358.3,2311,0)
 ;;=P9021^^24^177^20^^^^1
 ;;^UTILITY(U,$J,358.3,2311,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2311,1,1,0)
 ;;=1^P9021
 ;;^UTILITY(U,$J,358.3,2311,1,3,0)
 ;;=3^Red Blood Cells,Ea Unit
 ;;^UTILITY(U,$J,358.3,2312,0)
 ;;=P9022^^24^177^21^^^^1
 ;;^UTILITY(U,$J,358.3,2312,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2312,1,1,0)
 ;;=1^P9022
 ;;^UTILITY(U,$J,358.3,2312,1,3,0)
 ;;=3^Washed Red Blood Cells,Ea Unit
 ;;^UTILITY(U,$J,358.3,2313,0)
 ;;=P9023^^24^177^5^^^^1
 ;;^UTILITY(U,$J,358.3,2313,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2313,1,1,0)
 ;;=1^P9023
 ;;^UTILITY(U,$J,358.3,2313,1,3,0)
 ;;=3^Frozen Plasma,Pooled,SD
 ;;^UTILITY(U,$J,358.3,2314,0)
 ;;=P9034^^24^177^12^^^^1
 ;;^UTILITY(U,$J,358.3,2314,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2314,1,1,0)
 ;;=1^P9034
 ;;^UTILITY(U,$J,358.3,2314,1,3,0)
 ;;=3^Platelets,Pheresis
 ;;^UTILITY(U,$J,358.3,2315,0)
 ;;=P9035^^24^177^8^^^^1
 ;;^UTILITY(U,$J,358.3,2315,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2315,1,1,0)
 ;;=1^P9035
 ;;^UTILITY(U,$J,358.3,2315,1,3,0)
 ;;=3^Platelet Pheres Leuko Reduced
 ;;^UTILITY(U,$J,358.3,2316,0)
 ;;=P9036^^24^177^9^^^^1
 ;;^UTILITY(U,$J,358.3,2316,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2316,1,1,0)
 ;;=1^P9036
 ;;^UTILITY(U,$J,358.3,2316,1,3,0)
 ;;=3^Platelet Pheres Leukoredu Irrad
 ;;^UTILITY(U,$J,358.3,2317,0)
 ;;=P9038^^24^177^16^^^^1
 ;;^UTILITY(U,$J,358.3,2317,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2317,1,1,0)
 ;;=1^P9038
 ;;^UTILITY(U,$J,358.3,2317,1,3,0)
 ;;=3^RBC Irradiated
 ;;^UTILITY(U,$J,358.3,2318,0)
 ;;=P9039^^24^177^15^^^^1
 ;;^UTILITY(U,$J,358.3,2318,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2318,1,1,0)
 ;;=1^P9039
 ;;^UTILITY(U,$J,358.3,2318,1,3,0)
 ;;=3^RBC Deglycerolized
 ;;^UTILITY(U,$J,358.3,2319,0)
 ;;=P9040^^24^177^17^^^^1
 ;;^UTILITY(U,$J,358.3,2319,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2319,1,1,0)
 ;;=1^P9040
 ;;^UTILITY(U,$J,358.3,2319,1,3,0)
 ;;=3^RBC Leuko Reduced Irradiated
 ;;^UTILITY(U,$J,358.3,2320,0)
 ;;=P9044^^24^177^3^^^^1
 ;;^UTILITY(U,$J,358.3,2320,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2320,1,1,0)
 ;;=1^P9044
 ;;^UTILITY(U,$J,358.3,2320,1,3,0)
 ;;=3^Cryoprecip Reduced Plasma
 ;;^UTILITY(U,$J,358.3,2321,0)
 ;;=P9051^^24^177^1^^^^1
 ;;^UTILITY(U,$J,358.3,2321,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2321,1,1,0)
 ;;=1^P9051
 ;;^UTILITY(U,$J,358.3,2321,1,3,0)
 ;;=3^Blood,L/R,CMV-Neg
 ;;^UTILITY(U,$J,358.3,2322,0)
 ;;=P9052^^24^177^11^^^^1
 ;;^UTILITY(U,$J,358.3,2322,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2322,1,1,0)
 ;;=1^P9052
 ;;^UTILITY(U,$J,358.3,2322,1,3,0)
 ;;=3^Platelets,HLA-M,L/R,Ea Unit
 ;;^UTILITY(U,$J,358.3,2323,0)
 ;;=P9053^^24^177^14^^^^1
 ;;^UTILITY(U,$J,358.3,2323,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2323,1,1,0)
 ;;=1^P9053
 ;;^UTILITY(U,$J,358.3,2323,1,3,0)
 ;;=3^Plt,Pher,L/R CMV-Neg,Irr
 ;;^UTILITY(U,$J,358.3,2324,0)
 ;;=P9054^^24^177^2^^^^1
 ;;^UTILITY(U,$J,358.3,2324,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2324,1,1,0)
 ;;=1^P9054
 ;;^UTILITY(U,$J,358.3,2324,1,3,0)
 ;;=3^Blood,L/R,Froz/Degly/Wash
 ;;^UTILITY(U,$J,358.3,2325,0)
 ;;=P9055^^24^177^13^^^^1
 ;;^UTILITY(U,$J,358.3,2325,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2325,1,1,0)
 ;;=1^P9055
 ;;^UTILITY(U,$J,358.3,2325,1,3,0)
 ;;=3^Plt,Aph/Pher,L/R,CMV-Neg
 ;;^UTILITY(U,$J,358.3,2326,0)
 ;;=P9058^^24^177^19^^^^1
 ;;^UTILITY(U,$J,358.3,2326,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2326,1,1,0)
 ;;=1^P9058
 ;;^UTILITY(U,$J,358.3,2326,1,3,0)
 ;;=3^RBC,L/R,CMV-Neg,Irrad
 ;;^UTILITY(U,$J,358.3,2327,0)
 ;;=P9059^^24^177^7^^^^1
 ;;^UTILITY(U,$J,358.3,2327,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2327,1,1,0)
 ;;=1^P9059
 ;;^UTILITY(U,$J,358.3,2327,1,3,0)
 ;;=3^Plasma,Frz Between 8-24hrs
 ;;^UTILITY(U,$J,358.3,2328,0)
 ;;=38220^^24^178^1^^^^1
 ;;^UTILITY(U,$J,358.3,2328,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2328,1,1,0)
 ;;=1^38220
 ;;^UTILITY(U,$J,358.3,2328,1,3,0)
 ;;=3^BONE MARROW ASPIRATION
 ;;^UTILITY(U,$J,358.3,2329,0)
 ;;=38221^^24^178^2^^^^1
 ;;^UTILITY(U,$J,358.3,2329,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2329,1,1,0)
 ;;=1^38221
 ;;^UTILITY(U,$J,358.3,2329,1,3,0)
 ;;=3^BONE MARROW BIOPSY
 ;;^UTILITY(U,$J,358.3,2330,0)
 ;;=19000^^24^178^3^^^^1
 ;;^UTILITY(U,$J,358.3,2330,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2330,1,1,0)
 ;;=1^19000
 ;;^UTILITY(U,$J,358.3,2330,1,3,0)
 ;;=3^BREAST CYST ASPIRATION
 ;;^UTILITY(U,$J,358.3,2331,0)
 ;;=19100^^24^178^4^^^^1
 ;;^UTILITY(U,$J,358.3,2331,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2331,1,1,0)
 ;;=1^19100
 ;;^UTILITY(U,$J,358.3,2331,1,3,0)
 ;;=3^BREAST NEEDLE BIOPSY
 ;;^UTILITY(U,$J,358.3,2332,0)
 ;;=10022^^24^178^5^^^^1
 ;;^UTILITY(U,$J,358.3,2332,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,2332,1,1,0)
 ;;=1^10022
 ;;^UTILITY(U,$J,358.3,2332,1,3,0)
 ;;=3^FNA W/IMAGE
